Ignite Creation Date:
2024-05-05 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00670774
Status:
COMPLETED
Last Update Posted:
2018-06-26
First Post:
2008-04-28
Brief Title:
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
Sponsor:
Mark Stegall
Organization:
Mayo Clinic
Organization Data
Organization:
Mayo Clinic
Class:
OTHER
Study ID:
07-007208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mark Stegall
Lead Sponsor Class:
OTHER
Responsible Party:
Mark Stegall
Responsible Party Title:
MD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Mayo Clinic
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Alexion Pharmaceuticals Inc | INDUSTRY |